Prashant Tailor is an Ophthalmology physician. OpenAlex indexes 44 publications with 386 citations (h-index 10); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
100 Stein Plz Fl 1
Los Angeles, CA 900950001
Telephone
310-206-9566Provider last certified this registry record 1 Jul 2024.
Clinical trials
- Evaluating AI-Generated Plain Language Summaries on Patient Comprehension of Ophthalmology Notes Among English-Speaking Patients
Sponsor: University of California, Los Angeles
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Regeneron Healthcare Solutions, Inc.Program year20252 payments
- ABBVIE INC.Program year20253 payments
- Genentech USA, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
59%Corticosteroid32.3%Prednisolone Acetate100%Part D≥74 patientsPolymyxin-class Antibacterial11.6%Polymyxin B Sul-Trimethoprim100%Part D≥33 patients+ 2 more classes in this area
Anti-infectives
18.4%Fluoroquinolone Antibacterial18.4%Moxifloxacin100%Part D≥40 patientsMusculoskeletal
18.4%Cyclooxygenase Inhibitor18.4%Ketorolac Tromethamine100%Part D≥35 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Spectrum of Colopathy and Severe Polyposis Associated With Pentosan Polysulfate Sodium Maculopathy: A Retrospective Case Series
American Journal of Ophthalmology
2026 - Acute Paracentral Scotoma Following Cosmetic Penile Filler Injection
Retinal Cases & Brief Reports
2026 - Private equity in ophthalmology: geographic trends reveal urban-rural disparities in acquisitions and satellite expansion
Graefe s Archive for Clinical and Experimental Ophthalmology
2026 - The evolving role of artificial intelligence in ophthalmology: basic science, translation, and clinical integration
Current Opinion in Ophthalmology
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Ali Bijani
Babol University of Medical Sciences
Hamid Asayesh
Ayatollah Boroujerdi University
John J. Huang
Isfahan University of Medical Sciences
Fotis Topouzis
National University of Singapore
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”